Mesendo (TCA Cellular Therapy)

N/A

Report date: 2023/01/12 15:28:46

Base Information

Drug NameMesendo (TCA Cellular Therapy)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacementsAngiogenesis inducers

TargetsNot applicable

Therapy Area/IndicationsIschemiaPeripheral Vascular DiseasesPeripheral Arterial Disease +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTca Cellular Therapy Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTca Cellular Therapy Llc

Active IndicationsN/A

Inactive IndicationsIschemiaPeripheral Vascular DiseasesPeripheral Arterial Disease +[7]

Other Information

ATC CodeN/A